Showing results (341-350 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|August 13, 2013
Structural basis for hyperpermeability of tumor vessels in advanced lung adenocarcinoma complicated by pleural effusionMaya Damianovich, Goni Hout Siloni, Iris Barshack, et al.
Clinical Lung Cancer|January 5, 2016
Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung CancerYoshiomi Hatayama, Tatsuya Nakamura, Motohisa Suzuki, et al.
Clinical Lung Cancer|January 5, 2016
Early Stage Non-Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database AnalysisApar Kishor Ganti, Valerie Shostrom, Mohamed Alorabi, et al.
Clinical Lung Cancer|October 27, 2015
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) DatabasePrimo N Lara, James Moon, Mary W Redman, et al.
Clinical Lung Cancer|January 27, 2016
First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III TrialMark Boye, Xin Wang, Vichien Srimuninnimit, et al.
Clinical Lung Cancer|February 3, 2016
Diagnostic Value of Bronchoalveolar Lavage for Diagnosis of Suspected Peripheral Lung CancerPascal Bezel, Verena Tischler, Cecile Robinson, et al.
Clinical Lung Cancer|February 14, 2016
Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer ScreeningGeena X Wu, Leanne Goldstein, Jae Y Kim, et al.
Clinical Lung Cancer|September 6, 2015
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung CancerThomas E Stinchcombe, Hossein Borghaei, Scott S Barker, et al.
Clinical Lung Cancer|January 14, 2015
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized TrialDomenico Galetta, Saverio Cinieri, Salvatore Pisconti, et al.
Clinical Lung Cancer|December 8, 2014
How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III TrialHans H Strøm, Roy M Bremnes, Stein H Sundstrøm, et al.
Pageof 234